(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Akagera Medicines, Belen Calvo Uyarra, Ebola, EIB Global, HIV, investment, Lassa fever, Michael Fairbanks, partnership, Regis Rugemanshuro, Rwanda, sustainability, Thomas Östros, tuberculosis, vaccine, wellness
(IN BRIEF) GSK has submitted a regulatory application to the European Medicines Agency (EMA) to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine to adults aged 50-59 who are at increased risk for RSV disease. The … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adults Aged 50-59, COPD, GSK, NCT05590403, RSV Vaccination, vaccine
(IN BRIEF) BioNTech has achieved a significant milestone in expanding mRNA vaccine manufacturing in Africa with the inauguration of its Kigali site, which includes the first manufacturing unit known as BioNTainer. This move is part of BioNTech’s broader efforts to … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Africa, BioNTainer, BioNTech, Dr. Jean Kaseya, H.E. Macky Sall, H.E. Paul Kagame, H.E. Ursula von der Leyen, Hon. Annalena Baerbock, Moussa Faki Mahamat, mRNA Vaccine, Prof. Ugur Sahin, Rwanda, Sierk Poetting, vaccine
(IN BRIEF) Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize a vaccine candidate for extraintestinal pathogenic E. coli (ExPEC) that is currently in Phase 3 of clinical trials. ExPEC … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science
Tagged E. coli, E.mbrace, ExPEC, Janssen, partnership, Sanofi, SEPSIS, sustainability, Thomas Triomphe, vaccine
(IN BRIEF) EMA proposes Comirnaty Omicron XBB.1.5 vaccine for ages 6 months+, tailored to combat Omicron XBB.1.5 variant. One dose suffices for ages 5+, while kids 6 months to 4 years may need 1 or 3 doses based on prior … Read the full press release
(PRESS RELEASE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, and CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), have announced that their joint bid to … Read the full press release
Posted in Chemicals, Germany, Government, Healthcare, News, Pharma & Biotech, Technology
Tagged biotech site, Christian Hartel, CordenPharma, coronavirus pandemic, lipid nanoparticles, LNP, messenger ribonucleic acid, Michael Quirmbach, mRNA, pDNA, plasmid DNA, Susanne Leonhartsberger, vaccine, WACKER, Weinberg Campus
(PRESS RELEASE) LIVERPOOL, 21-Sep-2021 — /EuropaWire/ — University of Liverpool, one of the six original ‘red brick’ civic universities, has announced that its researchers are part of a new project to increase the number of care home staff that take … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Boots UK, Care England, care home staff, care homes, Day Lewis Pharmacy, Dr Alys Griffiths, Dr Amrish Patel, flu, flu vaccine, FluCare project, Liz Jones, National Care Forum, National Institute for Health Research, NIHR, pharmacists, Public Health England, researchers, UEA, University of East Anglia, University of Leicester, University of Liverpool, vaccine
(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an agreement between the Company and the European Commission has been reached that puts an end of the legal proceedings over … Read the full press release
Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of reduction in disease transmission of up to 67% (PRESS RELEASE) CAMBRIDGE, 3-Feb-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical … Read the full press release
(PRESS RELEASE) GENEVA, 26-Oct-2020 — /EuropaWire/ — CERN Medical Service, CERN’s unit responsible for the Organization’s occupational health & safety, has announced the dates of its flu vaccination campaign for 2020. As part of the flu vaccination campaign organised by … Read the full press release
Posted in Healthcare, News, Science, Switzerland, Technology
Tagged CERN Medical Service, CHIS, flu vaccination, vaccination, vaccine
Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system (PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused … Read the full press release
Posted in Belgium, European Union, France, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Advanced purchase agreement, COVID-19, COVID-19 vaccine, EC, European Commission, GSK, influenza vaccine, Sanofi, vaccine
(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the AZD1222 COVID-19 vaccine. Building … Read the full press release
The company received support of more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) Broad and equitable supply of the vaccine throughout the world at no profit during the pandemic First agreements for at least 400 … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acalabrutinib, Accord, AZD1222, CALAVI, Calquence, ChAdOx1 nCoV-19, COVID-19, dapagliflozin, DARE-19, Farxiga, pandemic, Pascal Soriot, University of Oxford, vaccine
(PRESS RELEASE) PARIS, 28-Apr-2020 — /EuropaWire/ — Digital transformation leader, Atos brings its technology leadership, skills and innovation resources to the global fight against Covid-19. Atos is involved on multiple fronts to help contain the spread of the virus, providing … Read the full press release
Posted in France, Healthcare, Industrial, News, Science, Technology
Tagged AI, Atos, Atos’ BullSequana, biomolecular simulations, CEA, CINES, COVID-19, CPU, digital transformation, Elie Girard, EMS, Epidemic Management System, epidemiological situation, EpiSYS, Hartree Centre, Healthcare, healthcare professionals, INNOVATION, JADE national, Joliot-Curie, Machine Learning, Occigen, pandemic, RESEARCH, Scottish Water, skills, STFC, supercomputers, supercomputing, technology leadership, TGCC, vaccine
LONDON, 14-May-2018 — /EuropaWire/ — Wellcome is making an initial fund of up to £2 million available to support a rapid response to the new Ebola outbreak in the Democratic Republic of Congo (DRC). The pledge comes after the DRC … Read the full press release
Posted in Financial, Healthcare, Non Profit, Society, United Kingdom
Tagged Congo, Dr Peter Salama, Ebola outbreak, fund, Jeremy Farrar, vaccine, Wellcome, WHO
Scientists say they have made a major breakthrough in the search for an effective vaccine for the neglected tropical disease leishmaniasis following the successful completion of a first in-human trial. YORK, 07-Jun-2017 — /EuropaWire/ — The team, led by researchers … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged leishmaniasis, Professor Paul Kaye, tropical disease, University of York, vaccine
Norwich, UK, 28-7-2014 — /EuropaWire/ — Giving parents access to online information about the MMR vaccine is the most cost-effective way of increasing its uptake according to research from the University of East Anglia and the University of Leeds. A new report … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged measles, MMR vaccine., mumps, Prof Francine Cheater, rubella, University of East Anglia, University of Leeds, vaccine
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
